What Can You Expect at the Premier European Bispecific Forum in 2026?
With Bispecific investment surging and multi-billion-dollar deals redefining the competitive landscape, the race is on to unlock new targets and next-generation multispecifics.
The Inaugural World Bispecific Summit Europe delivers:
- Exclusive perspectives
- Never-seen-before data
- Practical strategies from teams leading the field,
Gain actionable insights to accelerate innovative Bispecific design and translation to stay ahead of industry momentum
Unmissable Event Highlights for 2026:
De-Risk Bispecific, T-Cell Engager & Bispecific ADC Development from Concept to Clinic
Learn how leading biopharma teams are reducing toxicity, improving translation, and accelerating clinical progress
Insights from: Roche, Sanofi and AstraZeneca
Unlock Solid Tumour Success with Next-Generation Bispecifics
Explore innovative formats and targeting strategies designed to overcome historical efficacy and delivery challenges
Insights from: Philochem, Adaptam Therapeutics, Molecular Partners, Enara Bio & more
Design Safer, More Potent Immune-Engaging Therapies
Understand how smarter engineering and logic-gated approaches can expand the therapeutic window
Insights from: Genmab, LabGenius and Biomunex Pharmaceuticals
Stay Ahead of Emerging Targets, Modalities & Multispecific Innovation
Gain early insight into the next wave of bispecific, trispecific, and multispecific strategies shaping future pipelines
Insights from: UCB, Valink Therapeutics, NovelGen and Light Chain Bioscience
Attending Companies Include
Sorry, we couldn't find any posts. Please try a different search.